Health and Medicine
Dec. 10, 2020—Vanderbilt investigators have devised a system to alert health IT teams to deteriorating performance in clinical prediction models.
Dec. 10, 2020—COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients.
Dec. 10, 2020—David Calkins, PhD, director of the Vanderbilt Vision Research Center and vice chair and director for Research of the Department of Ophthalmology and Visual Sciences, has been appointed Assistant Vice President for Research at Vanderbilt University Medical Center.
Dec. 10, 2020—Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis.
Dec. 10, 2020—Nominations are being sought for the following 2021 Vanderbilt University School of Medicine Faculty Awards:
Dec. 8, 2020—After an extensive national search Alice Coogan, MD, interim chair of the Department and professor of Pathology, Microbiology and Immunology (PM&I), has been named as the department’s next chair, effective immediately. Coogan will be the seventh chair of the department and the first female chair.
Cortez named interim chair of the Department of Biochemistry; York named Impossible Foods chief science officer
Dec. 8, 2020—David Cortez, PhD, Richard N. Armstrong Professor of Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1, 2021.
Dec. 3, 2020—Six Vanderbilt University faculty members have been elected 2020 fellows of the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers.
Dec. 2, 2020—Researchers in the Vanderbilt University Institute of Imaging Science (VUIIS) have received a $1 million grant from the Chan Zuckerberg Initiative to develop “deep tissue” imaging methods that can peer into the furthest corners of the body.